Sagut, Jimmy A.

HRN: 21-74-40  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2022
CEFTRIAXONE 1G (VIAL)
08/03/2022
08/09/2022
IV
1g
Q12
Pneumonia
Waiting Final Action 
08/04/2022
AZITHROMYCIN 500MG TABLET (TAB)
08/04/2022
08/06/2022
PO
500 Mg
OD
Aspiration Pneumonia
Waiting Final Action 
08/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/06/2022
08/13/2022
IV
4.5g
Q8
Aspiration Pneumonia
Waiting Final Action 
08/13/2022
LEVOFLOXACIN 500MG (TAB)
08/13/2022
08/19/2022
PO
750mg
OD
ARF Type I Sec To HAP; T/C Typhoid Fever With Ileitis
Waiting Final Action 
08/13/2022
MUPIROCIN 2%, 15G (TUBE)
08/13/2022
08/20/2022
TOPICAL
2%
BID
Decubitus Ulcer
Waiting Final Action 
08/15/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/15/2022
08/22/2022
IV
4.5g
Q8
SEPSIS
Waiting Final Action 
08/16/2022
CEFTAZIDIME 1GM (VIAL)
08/16/2022
08/23/2022
IV
2gms
Q8
Copd In Exacerbation; Decubitus Ulcer; Recurrent Fever
Waiting Final Action 
08/16/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/16/2022
08/23/2022
IV
600mg
Q6
Copd In Exacerbation; Decubitus Ulcer; Recurrent Fever
Waiting Final Action 
08/17/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/17/2022
08/23/2022
TOPICAL
1%
OD
Sacral Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: